22 May 2013
Keywords: meningitis, cases, vioxx, reported, aim, journal, bextra
Article | 01 April 2002
Merck & Co's COX-2 inhibitor Vioxx (rofecoxib) has been associated with12 cases of nonbacterial meningitis since it become available in the
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
25 March 2002
22 April 2002
© 2013 thepharmaletter.com